StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.1
  1. Startseite
  2. /Verbindung

2-Thiouracil

Thiouracil

HCID 1269845
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
141-90-2
Standard-SMILES
O=c1cc[nH]c(=S)[nH]1
InChIKey
ZEMGGZBWXRYJHK-UHFFFAOYSA-N
Summenformel
C4H4N2OS
Durchschnittliche Molmasse
128,15 g/mol
Monoisotopische Masse
128,00443375

Überblick

Thiouracil can cause cancer according to The World Health Organization's International Agency for Research on Cancer (IARC).

Namen und Bezeichner

Bevorzugter Name
Thiouracil
IUPAC
2-sulfanylidene-1H-pyrimidin-4-one
Lokaler Name
2-Thiouracil
Englischer Name
2-Thiouracil
Summenformel
C4H4N2OS
Molmasse
128.15

Namen und Synonyme

2-thiouracilThiouracil141-90-2DeracilAntagothyroidAntagothyroilNobilen2-thioxo-2,3-dihydropyrimidin-4(1H)-one2-Mercapto-4-hydroxypyrimidine2-Mercapto-4-pyrimidone4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-6-Thiouracil
Weitere Namen anzeigen
TU2-Mercapto-4-pyriMidinone2-TU
2-Mercapto-4-pyrimidinolUracil, 2-thio-2-sulfanylidene-1H-pyrimidin-4-one4-Hydroxy-2-pyrimidinethiol2,3-Dihydro-2-thioxo-4(1H)-pyrimidinone6-Hydroxy-2-mercaptopyrimidine2-Thio-1,3-pyrimidin-4-one2-Mercapto-4(1H)-pyrimidinone

Datenbank-Bezeichner

CAS
141-90-2
PubChem CID
1269845
DTXSID
DTXSID4021347
ChEMBL
CHEMBL345768
ChEBI
CHEBI:348530
UNII
59X161SCYL
EC Number
205-508-8
Nikkaji
J9.741A

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
-0,3
Polarare Oberfläche (TPSA)
73,2 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
0
Schwere Atome
8
Formalladung
0
Komplexität
163

Experimentelle und physikochemische Eigenschaften

SpringerMaterials PropertiesDensity
LogP-0.65
OdorODORLESS
TasteBITTER TASTE
Color/Form · 2 Einträge

MINUTE CRYSTALS, PRISMS, OR WHITE OR PALE CREAM-COLORED POWDER

PRISMS FROM WATER OR ALC

Solubility · 2 Einträge

VERY SLIGHTLY SOL IN WATER (1:2000); PRACTICALLY INSOL IN ETHER, ACIDS; READILY SOL IN ALKALINE SOLN

SLIGHTLY SOL IN ALC; SOL IN ANHYD HYDROGEN FLUORIDE

Melting PointNO DEFINITE MP, ABOUT 340 °C WITH DECOMP
Collision Cross Section · 3 Einträge

116.1 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID4021347]

137.08 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

119.87 Ų [M+H]+

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 5.6% (4 of 71) of reports.

Warning

H351 (94.4%): Suspected of causing cancer [Warning Carcinogenicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 71 reports by companies from 5 notifications to the ECHA C&L Inventory.

Danger

Gefahrenhinweise

Regulatory Information · 3 Einträge

Chemical: 4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-

Hazard Traits - Carcinogenicity

4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and Categories · 3 Einträge

Carc. 2 (94.4%)

Acute toxicity (Oral) - Category 5

Acute toxicity (Oral) - Category 5

Toxikologische Informationen

Natural Pollution SourcesOCCURS IN SEEDS OF BRASSICA, CRUCIFERAE: PURVES, BRIT J EXP PATHOL 22, 241 (1941).
Human Toxicity Excerpts · 5 Einträge

HEMORRHAGE, PETECHIAE, PURPURA.

THIOURACIL CAN INDUCE HEPATIC INJURY. /FROM TABLE/

THESE DRUGS /WHICH INCL THIOURACIL/ HAVE CAUSED NUMEROUS TOXIC SIDE REACTIONS PRINCIPALLY...DRUG FEVER, SKIN ERUPTIONS, & ARTERITIS.

MATERNAL ANTI-THYROID MEDICATION...HAS RESULTED...IN DEVELOPMENT OF FETAL GOITER, & OCCASIONALLY IN HYPOTHYROIDISM IN SOME NEONATE LEADING TO MENTAL RETARDATION. ... JUST OCCASIONALLY, GOITER IN AFFECTED INFANTS MAY OBSTRUCT AIR PASSAGE, & CAUSE RESPIRATORY DISTRESS.

Chemie und Industrie

Pharmakologische Informationen

Mechanism of Action · 2 Einträge

ANTITHYROID DRUGS INHIBIT FORMATION OF THYROID HORMONE LARGELY BY INTERFERING WITH INCORPORATION OF IODINE INTO ORGANIC FORM. THIS IMPLIES THAT THEY INTERFERE WITH OXIDN OF IODIDE ION, BUT ELUCIDATION OF DETAILED MECHANISM... HAMPERED BY INCOMPLETE UNDERSTANDING OF IODIDE-OXIDIZING SYSTEM OF...GLAND. /ANTITHYROID DRUGS/

THIOAMIDE DERIV DO NOT HAVE PERMANENT EFFECT UPON THYROID GLAND BUT INHIBIT HORMONE SYNTHESIS & SECRETION UNTIL SPONTANEOUS REMISSION OCCURS DURING COURSE OF DISEASE. /THIOAMIDE DERIV/

Metabolism/Metabolites · 1 Eintrag

IN HOMOGENIZED RAT LIVER PREPN FROM FEMALE HOLTZMAN RATS, 28-35% OF THIOURACIL WAS METABOLIZED WITHIN 3 HR. PATHWAY FOR BREAKDOWN OF THIOURACIL WAS SUGGESTED TO BE AS FOLLOWS: URACIL; BETA-UREIDOPROPIONIC ACID, WHICH WAS FURTHER METABOLIZED TO BETA-ALANINE; AMMONIA & CARBON DIOXIDE...

MeSH Pharmacological Classification · 2 Einträge

Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.

Drugs used to cause dilation of the blood vessels.

Absorption, Distribution and Excretion · 5 Einträge

DRUG TRANSMISSION TO FETUS: TIME TO APPEAR IN FETUS 10 MIN; TIME TO FETAL/MATERNAL CONCN EQUILIBRIUM 40 MIN; FETAL/MATERNAL CONCN RATIO 1.0 /FROM TABLE/

/IN RATS/ ACCUMULATION OF (35)S LABEL WAS FASTER & OCCURRED TO GREATER EXTENT FROM SMALLER DOSE, SUGGESTING PRESENCE OF SATURABLE TRANSPORT MECHANISM. SIMILAR STUDIES WITH (14)C-THIOURACIL HAVE SHOWN ACCUM OF RADIOACTIVITY IN BOTH MATERNAL & FETAL THYROID TISSUES OF RABBITS...

...WITH BOTH LARGE (39 UMOL) & SMALL (1.2 UMOL) DOSES OF (35)S-THIOURACIL, CONSIDERABLE ACCUM OF BOTH TOTAL RADIOACTIVITY & UNMETABOLIZED (35)S-THIOURACIL OCCURS IN THYROID TISSUE RELATIVE TO PLASMA /IN RATS/.

THIOURACIL IS ABSORBED FROM GI TRACT IN RATS... IN RATS ADMIN 5 MG BY IV INJECTION, 30% OF THIOURACIL...RECOVERED FROM CARCASSES AFTER 3 HR & ONLY TRACES AFTER 24 HR.

For more Absorption, Distribution and Excretion (Complete) data for 2-THIOURACIL (7 total), please visit the HSDB record page.

Verwendung und Herstellung

Zugehörige Reaktionen

23
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 202391
HRID 202391als EduktTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
Reaktionsgleichung von HRID 223295
HRID 223295als Eduktuspto-grants-1982_10
Reaktionsgleichung von HRID 467809
HRID 467809als Eduktuspto-grants-2014_01
Reaktionsgleichung von HRID 598080
HRID 598080als Eduktuspto-grants-2011_03
Reaktionsgleichung von HRID 653189
HRID 653189als Eduktuspto-grants-1987_06
Reaktionsgleichung von HRID 714773
HRID 714773als Eduktuspto-grants-2015_11
Reaktionsgleichung von HRID 714893
HRID 714893als Eduktuspto-grants-2015_11
Reaktionsgleichung von HRID 834023
HRID 834023als EduktTest data from https://doi.org/10.1039/C8SC04228D
ZurückSeite 1 von 3

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Other Experimental Properties
FORMS PPT & COMPLEXES WITH HEAVY METALS & OTHER COMPD; REACTS WITH VARIOUS SULFHYDRYL REAGENTS

Physikochemische Eigenschaften

Schmelzpunkt
300 °C · >300 °C (lit.)
Dichte
1.368 · 1.368 (estimate)
Brechungsindex
1.7 · 1.7000 (estimate)
storage temp.
30 °C · Store below +30°C.
Löslichkeit
7.9 g/l · 7.9g/l
Aggregatzustand
Fine Crystalline Powder
pka
7.46 · pKa 7.46 (Uncertain)
Farbe
White to cream
Biologische Quelle
synthetic
Wasserlöslichkeit
0.5 g/L · 0.5 g/L
Merck
14 · 14,9366
BRN
112227 · 112227
InChI
1S/C4H4N2OS/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)
InChIKey
ZEMGGZBWXRYJHK-UHFFFAOYSA-N
SMILES
O=C1NC(=S)NC=C1
CAS Datenbank
141 · 141-90-2(CAS DataBase Reference)
NIST chemische Informationen
2 · 2-Thiouracil(141-90-2)
EPA chemische Informationen
Thiouracil (141-90-2)

For more Human Toxicity Excerpts (Complete) data for 2-THIOURACIL (6 total), please visit the HSDB record page.

Carcinogen Classification · 5 Einträge

Thiouracil

Group 2B: Possibly carcinogenic to humans

Volume Sup 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, 1987; 440 pages; ISBN 92-832-1411-0 (out of print)

2001

2000

Non-Human Toxicity Excerpts · 5 Einträge

DWARFISM & MENTAL RETARDATION...CAN BE PRODUCED IN RATS BY FEEDING DAMS...THIOURACIL...@ DIETARY LEVEL OF 1,000 PPM.

EIGHTY-ONE MICE OF 3 INBRED STRAINS (A, C57 & I) WERE ADMIN 0.1% THIOURACIL (TU) IN COMMERCIAL DIET FOR PERIODS OF UP TO 80 WK. IN 69 MICE EXAM, THYROIDAL FOLLICULAR CYSTS...FOUND & INTERPRETED BY AUTHORS AS NON-MALIGNANT LESIONS, SINCE THEY REGRESSED FOLLOWING WITHDRAWAL OF THIOURACIL...

OF 52 C STRAIN MICE (40 MALES & 12 FEMALES) ADMIN 0.37% THIOURACIL IN DIET FOR 6 MO FOLLOWED BY 0.5% FOR LIFE, LAST ANIMAL DIED @ 116 WK, & NODULAR HYPERPLASIS OF THYROID OCCURRED IN 28/39 MICE SURVIVING LONGER THAN 10 MO... IN (C57XCBA)F1 FEMALE MICE ADMIN 0.2% IN DIET...FROM 1-29 MO, HEPATOMAS...IN 6/21...ANIMALS.

NODULAR HYPERPLASIA OF THYROID WAS OBSERVED IN STANFORD ALBINO RATS OF BOTH SEXES AFTER ADMIN OF 0.1% THIOURACIL IN DIET FOR UP TO 45 WK. INCIDENCE IN MALES INCR FROM 3/10-11/20 AFTER TREATMENT FOR 29 & 45 WK, RESPECTIVELY. NO INCR...IN FEMALE RATS (3/10, COMPARED WITH 5/15) EXAM AFTER TREATMENT FOR 29 & 38 WK...

For more Non-Human Toxicity Excerpts (Complete) data for 2-THIOURACIL (9 total), please visit the HSDB record page.

Evidence for Carcinogenicity · 1 Eintrag

Evaluation: There is inadequate evidence in humans for the carcinogenicity of thiouracil. There is sufficient evidence in experimental animals for the carcinogenicity of thiouracil. Overall evaluation: Thiouracil is probably carcinogenic to humans (Group 2B).

Antidote and Emergency Treatment · 1 Eintrag

EARLIEST SIGN OF HYPOTHYROIDISM CALL FOR REDN IN DOSE; IF BY CHANCE THEY HAVE ADVANCED TO POINT OF DISCOMFORT, THYROID HORMONE CAN BE GIVEN TO HASTEN RECOVERY. FULL DOSE OF 120-180 MG DAILY OF THYROID OR EQUIV OF TYHROXINE OR TRIIODOTHYRONINE FOR WK WILL USUALLY SUFFICE. /ANTI-THYROID DRUGS/

Sicherheitsdaten

wgk
3
tsca
TSCA listed
hs_code
29335995
RTECS-Nr.
YR1575000
risk_code
40-45-20/21/22
hazard_code
Xn,T
safety_code
36/37-53-45
Speicherklasse
11 - Combustible Solids
Giftige Stoffe Daten
141-90-2(Hazardous Substances Data)
Hazard Classifications
Carc. 2
Selbstentzündungstemperatur
570°C
Uses · 3 Einträge

CHEM INT FOR IOTHIOURACIL SODIUM- AN ANTITHYROID AGENT

MEDICATION

MEDICATION (VET)

U.S. Exports · 2 Einträge

(1972) No Data

(1975) No Data

U.S. Imports · 2 Einträge

(1972) No Data

(1975) No Data

U.S. Production · 2 Einträge

(1974) PROBABLY GREATER THAN 4.54X10+5 GRAMS

(1975) PROBABLY GREATER THAN 4.54X10+5 GRAMS

Methods of Manufacturing · 2 Einträge

CONDENSATION OF ETHYL FORMYLACETATE WITH THIOUREA

PREPD BY CONDENSING ETHYL FORMYLACETATE WITH THIOUREA: WHEELER, LIDDLE, AM CHEM J 40, 550 (1908).

General Manufacturing Information · 2 Einträge

4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-: ACTIVE

THIOAMIDE DERIV USED IN THIS COUNTRY ARE PROPYLTHIOURACIL, METHIMAZOLE, & METHYLTHIOURACIL. THESE DRUGS HAVE REPLACED PARENT COMPD, THIOURACIL, WHICH IS MORE TOXIC.

Anwendungen

Verwenden2-Thiouracil has been used in the synthesis and characterization of silver colloid and film substrates and their applications in surface-enhanced Raman scattering (SERS)

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

NatriummethanolatThioharnstoff4-Aminopyrimidin-2-thiol2-Thiouridine

Nachgelagerte Produkte

Pyrimidin-4-ol4-Chloro-N-methylpyrimidin-2-amineN-(4-Aminopyrimidin-2-yl)-N-methylamine5-Bromo-4-chloro-2-methylsulfanyl-pyrimidine4-Bromopyrimidine4-Thiouracil3H-Pyrimidin-4-on1H-Pyrimidin-4-onBenzyl-(2-methylsulfanyl-pyrimidin-4-yl)-amine4-Chloro-2-(methylsulfonyl)pyrimidine5-Bromo-4-chloro-2-methanesulfonyl-pyrimidine2-(Methylthio)-1H-pyrimidin-4-on4-Chlor-2-methylthiopyrimidinDithiouracil5-(morpholinomethyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone4-Hydroxy-2-phenylpyrimidine

Ergänzende Hinweise

DefinitionChEBI: A nucleobase analogue that is uracil in which the oxo group at C-2 is replaced by a thioxo group.